Fny Investment Advisers, LLC Avrobio, Inc. Transaction History

Fny Investment Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$1.15 - $1.48 $373,750 - $481,000	-325,000 Reduced 81.25%	75,000 $96,000
Q4 2023 Jan 12, 2024	BUY	$1.22 - $1.62 $213,500 - $283,500	175,000 Added 77.78%	400,000 $544,000
Q3 2023 Oct 10, 2023	BUY	$0.98 - $1.62 $220,500 - $364,500	225,000 New	225,000 $346,000
Q1 2023 Apr 12, 2023	BUY	$0.76 - $1.82 $19,950 - $47,775	26,250 New	26,250 $26,000
Q3 2018 Oct 29, 2018	SELL	$26.95 - $52.7 $8,085 - $15,810	-300 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$28.08 - $31.2 $8,424 - $9,360	300 New	300 $8,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.